Navigation Links
Cantel Medical Acquires Jet Prep Ltd.
Date:11/6/2013

LITTLE FALLS, N.J., Nov. 6, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), has further enhanced its leading endoscopy product portfolio with the acquisition of Jet Prep Ltd.  Based in Herzliya, Israel, Jet Prep Ltd. is the developer of the Jet Prep Flushing Device, a novel single-use irrigation and aspiration catheter to improve visualization during colonoscopy procedures.  The Jet Prep Flushing Device has FDA 510(k) and CE Mark clearances and is ready for immediate commercialization by our global endoscopy sales forces.  The Jet Prep operation, which will be integrated into our Medivators Endoscopy business, will remain in Israel.  Led by David Nitsan, this group of R&D engineers will continue working on new product development.

Don Byrne, President of Medivators Endoscopy, stated, "This acquisition strengthens our position as a leading provider of novel products and solutions for GI endoscopy.  The Jet Prep product is an important addition to our growing portfolio of endoscopy products focused on infection control and improving patient safety and outcomes."

Cantel Medical's Executive Vice President and COO, Jorgen Hansen, added, "We see the Jet Prep product line as exactly the type of novel and highly differentiated product that Medivators should be introducing to the market.  We know there is strong demand from physicians for a unique solution to improving visualization and have high expectations for its success in the GI endoscopy market.  We remain confident in the continued strong growth of our Medivators Endoscopy business."

About Cantel Medical Corp.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products.  For further information, visit the Cantel website at www.cantelmedical.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.

 


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2013 Ended July 31, 2013
2. Record Date Of Cantel Medicals Regular Semiannual Dividend Changed To July 23, 2013
3. Cantel Medical Reports EPS of $0.33 vs. $0.30 on 8% Sales Increase for Third Quarter Ended April 30, 2013
4. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
5. Cantel Medical To Present At The Bank Of America Merrill Lynch Health Care Conference
6. Cantel Medical To Present At Needham 12th Annual Healthcare Conference
7. Cantel Medicals Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens Water Technologies Business Unit
8. Cantel Medical Reports EPS of $0.38 vs. $0.27 on 9% Sales Increase for Second Quarter Ended January 31, 2013
9. Cantel Medical Reports EPS of $0.35 vs. $0.23 for First Quarter Ended October 31, 2012
10. Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
11. Cantel Medical Corp. To Present At The CL King 10th Annual Best Ideas Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):